<p>根据 Fifth Third Bancorp 最近向证券交易委员会提交的 13F 文件，该公司在第二季度减少了对 Thermo Fisher Scientific Inc.（纽约证券交易所代码：TMO - 免费报告）股票的持仓，减少幅度为 7.5%。该公司在此期间出售了 26,156 股后，持有 321,225 股该医疗研究公司的股票。截至最近一次向证券交易委员会提交的文件，Fifth Third Bancorp 持有的 Thermo Fisher Scientific 的股份约占 0.09%，价值为 130,244,000 美元。</p>
<ul>
<li>现金流关注：Thermo Fisher、Energy Transfer 和网易</li>
</ul>
<p>其他一些机构投资者和对冲基金最近也对该公司的持仓进行了调整。CCM Investment Advisers LLC 在第二季度将其在 Thermo Fisher Scientific 的持股增加了 1.5%。CCM Investment Advisers LLC 现在拥有 31,344 股该医疗研究公司的股票，价值为 12,709,000 美元，此前在此期间又增持了 449 股。Sheets Smith Wealth Management 在第二季度将其在 Thermo Fisher Scientific 的持股增加了 26.8%。Sheets Smith Wealth Management 现在拥有 3,817 股该医疗研究公司的股票，价值为 1,547,000 美元，此前在此期间又增持了 807 股。Compagnie Lombard Odier SCmA 在第二季度将其在 Thermo Fisher Scientific 的持股增加了 12.2%。Compagnie Lombard Odier SCmA 现在拥有 280,728 股该医疗研究公司的股票，价值为 113,824,000 美元，此前在上个季度又增持了 30,461 股。Unified Investment Management 在第二季度将其在 Thermo Fisher Scientific 的持股增加了 16.9%。Unified Investment Management 现在拥有 968 股该医疗研究公司的股票，价值为 392,000 美元，此前在上个季度又增持了 140 股。最后，Town &amp; Country Bank &amp; Trust CO 以 First Bankers Trust CO 的名义在第二季度将其在 Thermo Fisher Scientific 的持股增加了 12.1%。Town &amp; Country Bank &amp; Trust CO 现在拥有 2,539 股该医疗研究公司的股票，价值为 1,029,000 美元，此前在上个季度又增持了 274 股。机构投资者持有该公司 89.23% 的股份。</p>
<h2>Thermo Fisher Scientific 价格表现</h2>
<p>周三，TMO 股票开盘价为 469.41 美元。Thermo Fisher Scientific Inc.的 52 周低点为 385.46 美元，52 周高点为 623.77 美元。该公司的 50 日移动平均价格为 474.01 美元，200 日移动平均价格为 448.70 美元。该公司的市值为 1772.5 亿美元，市盈率为 27.15，市盈增长比率为 2.54，贝塔值为 0.75。该公司的债务与股本比率为 0.65，速动比率为 1.50，流动比率为 1.93。</p>
<ul>
<li>安捷伦科技受益于对持久性化学物质的打击</li>
</ul>
<p>Thermo Fisher Scientific（纽约证券交易所代码：TMO - 获取免费报告）最近于 7 月 23 日（周三）公布了其财报。该医疗研究公司报告本季度每股收益为 5.36 美元，超出分析师一致预期的 5.22 美元，超出幅度为 0.14 美元。Thermo Fisher Scientific 的净利润率为 15.24%，股本回报率为 16.82%。该公司本季度的收入为 108.6 亿美元，而分析师一致预期为 106.8 亿美元。去年同期，该公司每股收益为 5.37 美元。Thermo Fisher Scientific 的季度收入同比增长了 2.9%。Thermo Fisher Scientific 已将其 2025 年第三季度的每股收益指引设定为 5.460-5.510 美元。2025 财年的指引为每股收益 22.220-22.840 美元。整体来看，股票分析师预计 Thermo Fisher Scientific Inc.在当前年度的每股收益为 23.28 美元。</p>
<h2>Thermo Fisher Scientific 股息公告</h2>
<p>该公司最近还宣布了一项季度股息，将于 10 月 15 日（周三）支付。9 月 15 日（周一）登记的投资者将获得每股 0.43 美元的股息。这相当于每年 1.72 美元的股息，收益率为 0.4%。该股息的除息日期为 9 月 15 日（周一）。Thermo Fisher Scientific 的股息支付比率（DPR）目前为 9.95%。</p>
<h2>分析师设定新目标价</h2>
<ul>
<li>S&amp;P 500 中增长最快的四大股息：买入、卖出还是持有？</li>
</ul>
<p>几家券商最近对 TMO 发表了评论。汇丰全球研究在 7 月 24 日（周四）的一份研究报告中将 Thermo Fisher Scientific 的股票评级从 “强力买入” 下调至 “持有”。加拿大丰业银行在 7 月 11 日（周五）的一份研究报告中将 Thermo Fisher Scientific 的股票评级从 “行业表现” 上调至 “行业超越”，并为该公司设定了 590.00 美元的目标价。汇丰在 7 月 24 日（周四）重申了 “持有” 评级，并为 Thermo Fisher Scientific 的股票设定了 510.00 美元的目标价。瑞银集团在 7 月 24 日（周四）将 Thermo Fisher Scientific 的股票目标价从 460.00 美元上调至 500.00 美元，并给予该公司 “中性” 评级。最后，巴克莱在 9 月 11 日（周四）将 Thermo Fisher Scientific 的股票评级从 “等权重” 上调至 “超配”，并将该公司的目标价从 490.00 美元上调至 550.00 美元。十六位投资分析师对该股票给予了买入评级，五位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “适度买入”，共识目标价为 588.35 美元。</p>
<p><strong>查看我们对 TMO 的最新分析</strong></p>
<h2>内部买卖情况</h2>
<p>在相关消息中，首席执行官 Marc N. Casper 于 8 月 22 日星期五出售了 10,000 股赛默飞世尔的股票。股票以平均价格 500.96 美元出售，总交易额为 5,009,600.00 美元。交易完成后，首席执行官持有公司 115,174 股股票，价值 57,697,567.04 美元。这笔交易代表了他们持股比例的 7.99% 的减少。该出售在向证券交易委员会的备案中披露，相关信息可在 SEC 网站上找到。此外，首席会计官 Joseph R. Holmes 于 8 月 29 日星期五出售了 385 股赛默飞世尔的股票。股票以平均价格 492.63 美元出售，总交易额为 189,662.55 美元。交易完成后，首席会计官直接持有公司 2,319 股股票，价值 1,142,408.97 美元。这代表了他们持股比例的 14.24% 的减少。该出售的披露信息可以在这里找到。内部人士在上个季度出售了 30,066 股公司股票，价值 14,182,963 美元。内部人士持有公司 0.33% 的股票。</p>
<h2>赛默飞世尔简介</h2>
<p>(免费报告)</p>
<p>赛默飞世尔科技公司在北美、欧洲、亚太地区及国际市场提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。公司的生命科学解决方案部门提供用于生物和医学研究、药物和疫苗的发现与生产，以及感染和疾病的诊断的试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比赛默飞世尔更好的股票</li>
<li>加拿大便士股票：它们能让你致富吗？</li>
<li>3 只量子计算 ETF 值得了解——而且为什么其中 2 只不持有 D-Wave</li>
<li>这些液化天然气股票准备迎来反弹吗？</li>
<li>忘掉关税，Landstar 和 West Fraser 仍然可以反弹</li>
<li>澳大利亚证券交易所（ASX）是什么</li>
<li>超级微型公司会是下一个大规模 AI 收购的对象吗？</li>
</ul>
<p><strong>想看看其他对 TMO 感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com，获取赛默飞世尔科技公司（NYSE:TMO - 免费报告）的最新 13F 备案和内部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在赛默飞世尔吗？</h2>
<p>在考虑投资赛默飞世尔之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而赛默飞世尔并不在名单上。</p>
<p>虽然赛默飞世尔目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

五三银行

赛默飞世尔

<p>五三银行减少了在赛默飞世尔（NYSE:TMO）中的持股比例，第二季度减持了 7.5%，出售了 26,156 股，剩余持有 321,225 股，价值约为 1.302 亿美元。其他机构投资者也调整了他们的持仓。赛默飞世尔的股票开盘价为 469.41 美元，市值为 1772.5 亿美元。该公司报告第二季度每股收益为 5.36 美元，超出预期，并宣布每股季度股息为 0.43 美元，将于 10 月 15 日支付</p>

<p>Fifth Third Bancorp lessened its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 7.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 321,225 shares of the medical research company's stock after selling 26,156 shares during the period. Fifth Third Bancorp owned approximately 0.09% of Thermo Fisher Scientific worth $130,244,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>根据 Fifth Third Bancorp 最近向证券交易委员会提交的 13F 文件，该公司在第二季度减少了对 Thermo Fisher Scientific Inc.（纽约证券交易所代码：TMO - 免费报告）股票的持仓，减少幅度为 7.5%。该公司在此期间出售了 26,156 股后，持有 321,225 股该医疗研究公司的股票。截至最近一次向证券交易委员会提交的文件，Fifth Third Bancorp 持有的 Thermo Fisher Scientific 的股份约占 0.09%，价值为 130,244,000 美元。</p>
</div><ul>
<li>Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase</li>
</ul>
<div class="lb-trans"><ul>
<li>现金流关注：Thermo Fisher、Energy Transfer 和网易</li>
</ul>
</div><p>A number of other institutional investors and hedge funds also recently made changes to their positions in the company. CCM Investment Advisers LLC lifted its holdings in shares of Thermo Fisher Scientific by 1.5% during the 2nd quarter. CCM Investment Advisers LLC now owns 31,344 shares of the medical research company's stock worth $12,709,000 after acquiring an additional 449 shares during the period. Sheets Smith Wealth Management lifted its holdings in shares of Thermo Fisher Scientific by 26.8% during the 2nd quarter. Sheets Smith Wealth Management now owns 3,817 shares of the medical research company's stock worth $1,547,000 after acquiring an additional 807 shares during the period. Compagnie Lombard Odier SCmA lifted its stake in Thermo Fisher Scientific by 12.2% in the 2nd quarter. Compagnie Lombard Odier SCmA now owns 280,728 shares of the medical research company's stock valued at $113,824,000 after purchasing an additional 30,461 shares during the last quarter. Unified Investment Management lifted its stake in Thermo Fisher Scientific by 16.9% in the 2nd quarter. Unified Investment Management now owns 968 shares of the medical research company's stock valued at $392,000 after purchasing an additional 140 shares during the last quarter. Finally, Town &amp; Country Bank &amp; Trust CO dba First Bankers Trust CO lifted its stake in Thermo Fisher Scientific by 12.1% in the 2nd quarter. Town &amp; Country Bank &amp; Trust CO dba First Bankers Trust CO now owns 2,539 shares of the medical research company's stock valued at $1,029,000 after purchasing an additional 274 shares during the last quarter. Institutional investors own 89.23% of the company's stock.</p>
<div class="lb-trans"><p>其他一些机构投资者和对冲基金最近也对该公司的持仓进行了调整。CCM Investment Advisers LLC 在第二季度将其在 Thermo Fisher Scientific 的持股增加了 1.5%。CCM Investment Advisers LLC 现在拥有 31,344 股该医疗研究公司的股票，价值为 12,709,000 美元，此前在此期间又增持了 449 股。Sheets Smith Wealth Management 在第二季度将其在 Thermo Fisher Scientific 的持股增加了 26.8%。Sheets Smith Wealth Management 现在拥有 3,817 股该医疗研究公司的股票，价值为 1,547,000 美元，此前在此期间又增持了 807 股。Compagnie Lombard Odier SCmA 在第二季度将其在 Thermo Fisher Scientific 的持股增加了 12.2%。Compagnie Lombard Odier SCmA 现在拥有 280,728 股该医疗研究公司的股票，价值为 113,824,000 美元，此前在上个季度又增持了 30,461 股。Unified Investment Management 在第二季度将其在 Thermo Fisher Scientific 的持股增加了 16.9%。Unified Investment Management 现在拥有 968 股该医疗研究公司的股票，价值为 392,000 美元，此前在上个季度又增持了 140 股。最后，Town &amp; Country Bank &amp; Trust CO 以 First Bankers Trust CO 的名义在第二季度将其在 Thermo Fisher Scientific 的持股增加了 12.1%。Town &amp; Country Bank &amp; Trust CO 现在拥有 2,539 股该医疗研究公司的股票，价值为 1,029,000 美元，此前在上个季度又增持了 274 股。机构投资者持有该公司 89.23% 的股份。</p>
</div><h2>Thermo Fisher Scientific Price Performance</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 价格表现</h2>
</div><p>TMO stock opened at $469.41 on Wednesday. Thermo Fisher Scientific Inc. has a 52-week low of $385.46 and a 52-week high of $623.77. The company has a fifty day moving average price of $474.01 and a 200-day moving average price of $448.70. The company has a market capitalization of $177.25 billion, a P/E ratio of 27.15, a PEG ratio of 2.54 and a beta of 0.75. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.50 and a current ratio of 1.93.</p>
<div class="lb-trans"><p>周三，TMO 股票开盘价为 469.41 美元。Thermo Fisher Scientific Inc.的 52 周低点为 385.46 美元，52 周高点为 623.77 美元。该公司的 50 日移动平均价格为 474.01 美元，200 日移动平均价格为 448.70 美元。该公司的市值为 1772.5 亿美元，市盈率为 27.15，市盈增长比率为 2.54，贝塔值为 0.75。该公司的债务与股本比率为 0.65，速动比率为 1.50，流动比率为 1.93。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技受益于对持久性化学物质的打击</li>
</ul>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share for the quarter, topping analysts' consensus estimates of $5.22 by $0.14. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The business had revenue of $10.86 billion during the quarter, compared to the consensus estimate of $10.68 billion. During the same quarter last year, the firm earned $5.37 earnings per share. Thermo Fisher Scientific's quarterly revenue was up 2.9% on a year-over-year basis. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. As a group, equities analysts expect that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.</p>
<div class="lb-trans"><p>Thermo Fisher Scientific（纽约证券交易所代码：TMO - 获取免费报告）最近于 7 月 23 日（周三）公布了其财报。该医疗研究公司报告本季度每股收益为 5.36 美元，超出分析师一致预期的 5.22 美元，超出幅度为 0.14 美元。Thermo Fisher Scientific 的净利润率为 15.24%，股本回报率为 16.82%。该公司本季度的收入为 108.6 亿美元，而分析师一致预期为 106.8 亿美元。去年同期，该公司每股收益为 5.37 美元。Thermo Fisher Scientific 的季度收入同比增长了 2.9%。Thermo Fisher Scientific 已将其 2025 年第三季度的每股收益指引设定为 5.460-5.510 美元。2025 财年的指引为每股收益 22.220-22.840 美元。整体来看，股票分析师预计 Thermo Fisher Scientific Inc.在当前年度的每股收益为 23.28 美元。</p>
</div><h2>Thermo Fisher Scientific Dividend Announcement</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 股息公告</h2>
</div><p>The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Monday, September 15th will be paid a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, September 15th. Thermo Fisher Scientific's dividend payout ratio (DPR) is currently 9.95%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度股息，将于 10 月 15 日（周三）支付。9 月 15 日（周一）登记的投资者将获得每股 0.43 美元的股息。这相当于每年 1.72 美元的股息，收益率为 0.4%。该股息的除息日期为 9 月 15 日（周一）。Thermo Fisher Scientific 的股息支付比率（DPR）目前为 9.95%。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><ul>
<li>Top 4 Fastest Growing S&amp;P 500 Dividends: Buy, Sell, or Hold?</li>
</ul>
<div class="lb-trans"><ul>
<li>S&amp;P 500 中增长最快的四大股息：买入、卖出还是持有？</li>
</ul>
</div><p>Several brokerages recently commented on TMO. Hsbc Global Res downgraded shares of Thermo Fisher Scientific from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Thursday, July 24th. Scotiabank raised shares of Thermo Fisher Scientific from a &#34;sector perform&#34; rating to a &#34;sector outperform&#34; rating and set a $590.00 price objective for the company in a research note on Friday, July 11th. HSBC reissued a &#34;hold&#34; rating and issued a $510.00 price objective on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. UBS Group raised their price target on shares of Thermo Fisher Scientific from $460.00 to $500.00 and gave the company a &#34;neutral&#34; rating in a research note on Thursday, July 24th. Finally, Barclays raised shares of Thermo Fisher Scientific from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and raised their price target for the company from $490.00 to $550.00 in a research note on Thursday, September 11th. Sixteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $588.35.</p>
<div class="lb-trans"><p>几家券商最近对 TMO 发表了评论。汇丰全球研究在 7 月 24 日（周四）的一份研究报告中将 Thermo Fisher Scientific 的股票评级从 “强力买入” 下调至 “持有”。加拿大丰业银行在 7 月 11 日（周五）的一份研究报告中将 Thermo Fisher Scientific 的股票评级从 “行业表现” 上调至 “行业超越”，并为该公司设定了 590.00 美元的目标价。汇丰在 7 月 24 日（周四）重申了 “持有” 评级，并为 Thermo Fisher Scientific 的股票设定了 510.00 美元的目标价。瑞银集团在 7 月 24 日（周四）将 Thermo Fisher Scientific 的股票目标价从 460.00 美元上调至 500.00 美元，并给予该公司 “中性” 评级。最后，巴克莱在 9 月 11 日（周四）将 Thermo Fisher Scientific 的股票评级从 “等权重” 上调至 “超配”，并将该公司的目标价从 490.00 美元上调至 550.00 美元。十六位投资分析师对该股票给予了买入评级，五位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “适度买入”，共识目标价为 588.35 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on TMO</strong></p>
<div class="lb-trans"><p><strong>查看我们对 TMO 的最新分析</strong></p>
</div><h2>Insider Buying and Selling</h2>
<div class="lb-trans"><h2>内部买卖情况</h2>
</div><p>In related news, CEO Marc N. Casper sold 10,000 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $500.96, for a total transaction of $5,009,600.00. Following the completion of the transaction, the chief executive officer owned 115,174 shares of the company's stock, valued at $57,697,567.04. This trade represents a 7.99% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at the SEC website. Also, CAO Joseph R. Holmes sold 385 shares of Thermo Fisher Scientific stock in a transaction on Friday, August 29th. The stock was sold at an average price of $492.63, for a total transaction of $189,662.55. Following the transaction, the chief accounting officer directly owned 2,319 shares of the company's stock, valued at $1,142,408.97. This represents a 14.24% decrease in their position. The disclosure for this sale can be found here. Insiders sold 30,066 shares of company stock valued at $14,182,963 over the last quarter. Insiders own 0.33% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 Marc N. Casper 于 8 月 22 日星期五出售了 10,000 股赛默飞世尔的股票。股票以平均价格 500.96 美元出售，总交易额为 5,009,600.00 美元。交易完成后，首席执行官持有公司 115,174 股股票，价值 57,697,567.04 美元。这笔交易代表了他们持股比例的 7.99% 的减少。该出售在向证券交易委员会的备案中披露，相关信息可在 SEC 网站上找到。此外，首席会计官 Joseph R. Holmes 于 8 月 29 日星期五出售了 385 股赛默飞世尔的股票。股票以平均价格 492.63 美元出售，总交易额为 189,662.55 美元。交易完成后，首席会计官直接持有公司 2,319 股股票，价值 1,142,408.97 美元。这代表了他们持股比例的 14.24% 的减少。该出售的披露信息可以在这里找到。内部人士在上个季度出售了 30,066 股公司股票，价值 14,182,963 美元。内部人士持有公司 0.33% 的股票。</p>
</div><h2>Thermo Fisher Scientific Profile</h2>
<div class="lb-trans"><h2>赛默飞世尔简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.</p>
<div class="lb-trans"><p>赛默飞世尔科技公司在北美、欧洲、亚太地区及国际市场提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。公司的生命科学解决方案部门提供用于生物和医学研究、药物和疫苗的发现与生产，以及感染和疾病的诊断的试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>Canadian Penny Stocks: Can They Make You Rich?</li>
<li>3 Quantum Computing ETFs to Know—And Why 2 Don't Hold D-Wave</li>
<li>Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?</li>
<li>Forget Tariffs, Landstar and West Fraser Can Still Rally</li>
<li>What is the Australian Securities Exchange (ASX)</li>
<li>Is Super Micro Next in Line for a Big AI Takeover?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比赛默飞世尔更好的股票</li>
<li>加拿大便士股票：它们能让你致富吗？</li>
<li>3 只量子计算 ETF 值得了解——而且为什么其中 2 只不持有 D-Wave</li>
<li>这些液化天然气股票准备迎来反弹吗？</li>
<li>忘掉关税，Landstar 和 West Fraser 仍然可以反弹</li>
<li>澳大利亚证券交易所（ASX）是什么</li>
<li>超级微型公司会是下一个大规模 AI 收购的对象吗？</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding TMO?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 TMO 感兴趣的对冲基金持有哪些股票吗？</strong> 访问 HoldingsChannel.com，获取赛默飞世尔科技公司（NYSE:TMO - 免费报告）的最新 13F 备案和内部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在赛默飞世尔吗？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资赛默飞世尔之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而赛默飞世尔并不在名单上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然赛默飞世尔目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

五三银行出售了赛默飞世尔科技公司 26,156 股股票 $TMO